Jeil Pharma Holdings Inc
002620.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$115.9B
Close$
Share Statistics
| Market cap | $115.90 Billion |
|---|---|
| Enterprise Value | $241.87 Billion |
| Dividend Yield | $70.00 (0.93%) |
| Earnings per Share | $953.37 |
| Beta | 0.54 |
| Outstanding Shares | 15,351,000 |
Return
| Return on Equity | 2.68% |
|---|---|
| Return on Assets | 0.95% |
| Return on Invested Capital | -9.77% |
Valuation & Multiples
| P/E Ratio | 13.73 |
|---|---|
| PEG | -4.01 |
| Price to Sales | 0.18 |
| Price to Book Ratio | 0.24 |
| Enterprise Value to Revenue | 0.39 |
| Enterprise Value to EBIT | -4.4 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.78 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jeil Pharma Holdings Inc
40 employees
CEO: Seung-Soo Han Jeil Pharma Holdings Inc. is a South Korean pharmaceutical enterprise focused on the production and sale of active pharmaceutical ingredients (APIs), incrementally modified drugs (IMDs), and generic pharmaceuticals. The company's compreh...